200 related articles for article (PubMed ID: 9300746)
21. Radiation therapy of glottic carcinoma: Peter MacCallum Cancer Institute experience.
Guiney M; Smith J; Hughes P; Narayan K
Aust N Z J Surg; 1992 Aug; 62(8):622-7. PubMed ID: 1642583
[TBL] [Abstract][Full Text] [Related]
22. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications.
Mendenhall WM; Parsons JT; Million RR; Fletcher GH
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1267-73. PubMed ID: 3143690
[TBL] [Abstract][Full Text] [Related]
23. A critical review of radiotherapy in the management of T1 glottic carcinoma.
Morris MR; Canonico D; Blank C
Am J Otolaryngol; 1994; 15(4):276-80. PubMed ID: 7978026
[TBL] [Abstract][Full Text] [Related]
24. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
25. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns.
Turesson I; Sandberg N; Mercke C; Johansson KA; Sandin I; Wallgren A
Acta Oncol; 1991; 30(3):357-62. PubMed ID: 2036247
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionation reduces the therapeutic ratio in early glottic carcinoma.
Harrison D; Crennan E; Cruickshank D; Hughes P; Ball D
Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):365-72. PubMed ID: 3403317
[TBL] [Abstract][Full Text] [Related]
27. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx.
Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ
Am J Otolaryngol; 1994; 15(4):250-7. PubMed ID: 7978023
[No Abstract] [Full Text] [Related]
28. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif.
Lusinchi A; Dube P; Wibault P; Kunkler I; Luboinski B; Eschwege F
Radiother Oncol; 1989 Aug; 15(4):313-9. PubMed ID: 2798936
[TBL] [Abstract][Full Text] [Related]
29. A therapeutic approach to early vocal cord carcinoma.
Amornmarn R; Prempree T; Viravathana T; Donavanik V; Wizenberg MJ
Acta Radiol Oncol; 1985; 24(4):321-5. PubMed ID: 2994388
[TBL] [Abstract][Full Text] [Related]
30. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of time-dose factors in glottic tumors.
Luk KH; Castro JR
Acta Radiol Ther Phys Biol; 1975 Dec; 14(6):529-36. PubMed ID: 1224994
[TBL] [Abstract][Full Text] [Related]
32. T1-T2 vocal cord carcinoma: a basis for comparing the results of radiotherapy and surgery.
Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ; Million RR
Head Neck Surg; 1988; 10(6):373-7. PubMed ID: 3146560
[TBL] [Abstract][Full Text] [Related]
33. Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil.
Moose BD; Kelly MD; Levine PA; Constable WC; Cantrell RW; Larner JM
Head Neck; 1995; 17(4):334-8. PubMed ID: 7672974
[TBL] [Abstract][Full Text] [Related]
34. Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus.
Kajanti M; Kaleta R; Kankaanranta L; Muhonen T; Holsti L
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1017-23. PubMed ID: 7607921
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy of early glottic cancer.
Harwood AR; Hawkins NV; Keane T; Cummings B; Beale FA; Rider WD; Bryce DP
Laryngoscope; 1980 Mar; 90(3):465-70. PubMed ID: 7359967
[TBL] [Abstract][Full Text] [Related]
36. Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y; Yasuda K; Minatogawa H; Uchinami Y; Tsushima N; Suzuki T; Kano S; Mori T; Nishioka K; Kobashi K; Katoh N; Homma A; Aoyama H
J Radiat Res; 2024 Jan; 65(1):63-70. PubMed ID: 37952082
[TBL] [Abstract][Full Text] [Related]
37. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx.
Parsons JT; Mendenhall WM; Mancuso AA; Cassisi NJ; Stringer SP; Million RR
Head Neck; 1989; 11(2):123-8. PubMed ID: 2722488
[TBL] [Abstract][Full Text] [Related]
38. Reasons for irradiation failure in squamous cell carcinoma of the larynx.
Fletcher GH; Lindberg RD; Hamberger A; Horiot JC
Laryngoscope; 1975 Jun; 85(6):987-1003. PubMed ID: 1142974
[TBL] [Abstract][Full Text] [Related]
39. Treatment of carcinoma of the vocal cord. A review of 20 years experience.
Woodhouse RJ; Quivey JM; Fu KK; Sien PS; Dedo HH; Phillips TL
Laryngoscope; 1981 Jul; 91(7):1155-62. PubMed ID: 7242207
[TBL] [Abstract][Full Text] [Related]
40. Primary radiation therapy for T1 glottic cancer. Factors influencing local control.
Minja BM; van den Broek P; Huygen PL; Kazem I
Clin Otolaryngol Allied Sci; 1984 Apr; 9(2):93-8. PubMed ID: 6432379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
